Psilocybin eases pain, depression in mice
Psilocybin in mice: rewires brain circuits, eases pain and depression for up to two weeks.
Why it matters
- Psilocybin may rewire brain circuits, offering a non-addictive alternative to opioids.
- Could lead to new treatments for chronic pain and depression.
By the numbers
- Single dose of psilocybin.
- Up to two weeks of relief in mice.
The big picture
- Chronic pain and depression are major health challenges.
- Opioids are addictive; psilocybin could be a safer option.
- Early-stage research but promising for future therapies.
What they're saying
- Some question how depression is measured in mice.
- Anecdotal reports vary: some see relief, others report worsened symptoms.
Caveats
- Study limited to mice; human trials needed.
- Individual experiences with psilocybin vary widely.
What’s next
- Human studies to confirm efficacy and safety.
- Further research into long-term effects and mechanisms.